Solu Therapeutics raises funds to develop CyTaC platform and drugs

Solu Therapeutics has raised $31m in seed financing to develop the Cytotoxicity Targeting Chimera (CyTaC) platform and drug candidates.

Related Keywords

Alexandria ,Al Iskandariyah ,Egypt ,Peter Hutt ,John Hamer ,David Donabedian ,Satoshi Konagai ,Omar Khalil ,Christoph Westphal ,Longwood Fund ,Alexandria Venture Investments ,Astellas Venture Management ,Therapeutic Cytac ,Solu Therapeutics ,